UNSPSC 85543218: Restriction of right axillary lymphatic with extraluminal device, percutaneous endoscopic approach

This classification denotes the group of activities that yields a surgical intervention or procedure to restriction of right axillary lymphatic with extraluminal device, percutaneous endoscopic approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 07V54CZ

UNSPSC 85543218 Restriction of right axillary lymphatic with extraluminal device, percutaneous endoscopic approach is a Commodity code that shows little relevant recent activity aligned with its nominal medical procedure scope. The recent opportunities tagged under this code do not reflect the specific lymphatic intervention the code describes; instead, they represent a broad range of health services procurement—occupational medical surveillance, pharmacy benefit management, temporary clinical staffing, independent disability evaluations, surgical carve-out networks, and emergency care for detained youth. The mismatch between the code's technical procedure name and the actual work being solicited suggests either tagging error or classification drift in the state and local procurement system.

The issuing bodies span state health departments, county human resources and probation functions, city retirement offices, and municipal health systems across Arizona, California, Florida, and Washington. Representative recent opportunities include the City of Phoenix Retirement Office's RFP for independent medical evaluation services (due October 16, 2026, $750,000 maximum over five years), the Washington State Department of Transportation's RFP for occupational medical surveillance across 14 ferry locations (due October 9, 2026), the County of Santa Clara Health System's qualification vehicle for temporary ancillary clinical staffing (due October 7, 2026), and the City of Long Beach's RFP for surgical carve-out benefits through Centers of Excellence (due October 7, 2026). No bidder should assume this code reliably identifies procurement opportunities in lymphatic or endoscopic procedures; activity under this number appears to reflect general-purpose health services contracting rather than the specific intervention the code nominally describes.